---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-262285"
form_type: "8-K"
ticker: null
cik: "0001780097"
company_name: "Baudax Bio, Inc."
filed_at: "2023-10-25T23:59:59+00:00"
generated_at: "2026-06-09T11:16:50.091482+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Baudax Bio dismisses EisnerAmper as auditor, engages KPMG; cites material weakness

## Summary
- Dismissed EisnerAmper on Oct 19, 2023; KPMG appointed as new independent auditor for FY 2023.
- EisnerAmper's 2022 report included a going-concern paragraph citing $190.9M accumulated deficit.
- Material weakness identified in Q2 2023 related to purchase price accounting for TeraImmune acquisition; no restatement.
- No disagreements between Company and EisnerAmper; KPMG previously served as auditor from 2019 to June 2022.
- Audit committee recommended change after competitive review; EisnerAmper letter filed as Exhibit 16.1.

## SEC filing metadata
- accession: 0001193125-23-262285
- form_type: 8-K
- cik: 0001780097
- company_name: Baudax Bio, Inc.
- filed_at: 2023-10-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1780097/000119312523262285/0001193125-23-262285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1780097/000119312523262285/d564363d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-262285
- JSON: https://secwatch.observer/filing/0001193125-23-262285.json
- Plain text: https://secwatch.observer/filing/0001193125-23-262285.txt

## Key facts
- Auditor Changes
  Baudax Bio, Inc. dismissed EisnerAmper LLP as its auditor.
  - Action: dismissal
  - Auditor: EisnerAmper LLP
  - Successor: KPMG LLP
  source text: ☒ Item 4.01 Change in Registrant’s Certifying Accountant Dismissal of Independent Registered Public Accounting Firm On October 19, 2023, Baudax Bio, Inc. (the “Company”) dismissed EisnerAmper LLP (“EisnerAmper”) as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1780097/000119312523262285/0001193125-23-262285-index.htm
- Auditor Changes
  Baudax Bio, Inc. engaged KPMG LLP as its auditor.
  - Action: engagement
  - Auditor: KPMG LLP
  source text: EisnerAmper has been authorized by the Company to respond fully to the inquiries of KPMG, the successor accountant, concerning this reportable event. The Company provided EisnerAmper with a copy of the disclosures in this Current Report on Form 8-K prior to its filing with the Commission and requested EisnerAmper furnish it a letter addressed to the Commission stating whether it agrees with the above statements. A copy of that letter, dated October 19, 2023, is filed as Exhibit 16.1 to this Current Report on Form 8-K. Engagement of Former Independent Registered Public Accounting Firm On October 19, 2023, in connection with the Company’s dismissal of EisnerAmper, the Board approved the engagement of KPMG LLP (“KPMG”) as its new independent registered public accounting firm to audit the Company’s financial statements for the year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1780097/000119312523262285/0001193125-23-262285-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.